Review paper

Emerging muscarinic receptor antagonists for the treatment of asthma

Volume: 25, Issue: 2, Pages: 123 - 130
Published: Apr 2, 2020
Abstract
Introduction The increased acetylcholine signaling in asthma pathophysiology offers the rationale for the use of LAMAs in the treatment of asthmatic patients. Tiotropium is still the only LAMA approved for use in asthma but there is a real interest in developing novel LAMAs for the treatment of asthma, or at least to extend this indication to other LAMAs already on the market.Areas covered We examined and discussed trials and research that have...
Paper Details
Title
Emerging muscarinic receptor antagonists for the treatment of asthma
Published Date
Apr 2, 2020
Volume
25
Issue
2
Pages
123 - 130
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.